Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.
Larrea
Carlos Fernández-de
CF
Cofan
Frederic
F
Oppenheimer
Federico
F
Campistol
Josep Maria
JM
Escolar
Gines
G
Lozano
Miguel
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D010951:Plasma Exchange; D012008:Recurrence; D016896:Treatment Outcome; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C481642:eculizumab